CERUSO, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 5.194
EU - Europa 1.414
AS - Asia 983
SA - Sud America 250
OC - Oceania 22
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.884
Nazione #
US - Stati Uniti d'America 5.176
RU - Federazione Russa 721
SG - Singapore 267
HK - Hong Kong 229
BR - Brasile 207
IE - Irlanda 194
IT - Italia 178
CN - Cina 157
KR - Corea 122
VN - Vietnam 110
SE - Svezia 89
FI - Finlandia 64
DE - Germania 44
IN - India 42
PL - Polonia 34
ES - Italia 30
AU - Australia 22
GB - Regno Unito 21
EC - Ecuador 14
BD - Bangladesh 12
AR - Argentina 11
CA - Canada 10
CI - Costa d'Avorio 10
FR - Francia 9
ID - Indonesia 9
UA - Ucraina 9
CO - Colombia 6
JO - Giordania 6
JP - Giappone 6
TR - Turchia 6
NL - Olanda 5
PK - Pakistan 5
PY - Paraguay 5
CH - Svizzera 4
AL - Albania 3
CL - Cile 3
DZ - Algeria 3
MX - Messico 3
PA - Panama 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
IQ - Iraq 2
KE - Kenya 2
SA - Arabia Saudita 2
VE - Venezuela 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.884
Città #
Santa Clara 1.333
Fairfield 766
Ashburn 394
Woodbridge 349
Seattle 318
Houston 290
Cambridge 275
Wilmington 212
Dublin 194
Hong Kong 180
Singapore 169
Chandler 153
Princeton 122
Seoul 122
Altamura 110
Lawrence 97
Ann Arbor 95
Clifton 52
Ho Chi Minh City 44
Beijing 41
Boston 38
Warsaw 34
Los Angeles 33
Barcelona 30
Medford 29
Florence 28
Kent 27
Moscow 26
Mumbai 24
Hanoi 23
San Diego 23
Melbourne 22
Redondo Beach 22
Shanghai 21
Buffalo 19
São Paulo 19
Munich 18
Falls Church 16
The Dalles 16
Boardman 15
New York 14
Dallas 12
Hefei 11
Abidjan 10
Falkenstein 10
Gavirate 10
Chicago 9
Norwalk 9
Brooklyn 8
London 8
Turku 8
Guayaquil 7
Hillsboro 7
Laurel 6
New Delhi 6
Rio de Janeiro 6
Rome 6
Tokyo 6
Andover 5
Guangzhou 5
Jakarta 5
Quito 5
Toronto 5
Belo Horizonte 4
Bern 4
Frankfurt am Main 4
Lahore 4
Paris 4
San Francisco 4
Acton 3
Americana 3
Amsterdam 3
Asunción 3
Betim 3
Brasília 3
Council Bluffs 3
Da Nang 3
Detroit 3
Goiânia 3
Helsinki 3
Las Vegas 3
Maceió 3
Manaus 3
Misano Adriatico 3
Panama City 3
Redmond 3
Ribeirão Preto 3
Tashkent 3
Tirana 3
Yaroslavl 3
Yubileyny 3
Araguaína 2
Bari 2
Biên Hòa 2
Bogotá 2
Brussels 2
Bình Dương 2
Bắc Ninh 2
Camaçari 2
Cape Town 2
Totale 6.085
Nome #
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies 200
Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties 189
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy 185
Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components 183
7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII 172
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 168
Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide derivatives bearing a sulfonamide moiety show single-digit nanomolar-to-subnanomolar inhibition constants against the tumor-associated human carbonic anhydrases IX and XII 167
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 167
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations 165
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII 161
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII 160
New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII 157
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 157
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 157
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII 156
Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds 153
Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII 151
New natural product carbonic anhydrase inhibitors incorporating phenol moieties 149
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms 146
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: Identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones 145
Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma 144
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII 144
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 141
Carbonic anhydrase inhibitors: Design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives 139
4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII 138
New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity 138
Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors 137
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis 137
Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae 137
Arylamino bisphosphonates: Potent and selective inhibitors of the tumor-associated carbonic anhydrase XII 136
Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV. 135
Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms 135
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 134
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties 132
Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII 132
Structure–Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity 130
Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: Synthesis, biological evaluation and molecular modelling studies 129
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors 128
Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds 127
Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties 127
Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII 127
Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity 126
Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 125
Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling 124
Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives 123
Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides 122
Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies 120
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi 119
Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action 119
Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase. 117
New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors 117
Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. 114
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 113
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 109
5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors 103
Sulfonamides with potent inhibitory action and selectivity against the α-carbonic anhydrase from Vibrio cholerae 101
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff’s bases incorporating iminoureido moieties 94
Totale 7.961
Categoria #
all - tutte 22.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 0 0 0 32 9 43 55 118 48 27
2021/2022343 14 4 43 10 6 24 9 35 16 23 34 125
2022/2023876 153 241 47 48 40 127 118 30 44 3 18 7
2023/2024212 9 24 61 9 19 11 4 29 2 8 28 8
2024/20252.646 112 227 108 284 1.099 401 63 154 39 46 60 53
2025/20261.160 172 322 160 229 257 20 0 0 0 0 0 0
Totale 7.961